Literature DB >> 25126454

Actinic granuloma.

Reza Yaghoob1, Nastaran Ranjbari2, Amir Feily3.   

Abstract

Entities:  

Keywords:  actinic granuloma; elastin fiber

Year:  2014        PMID: 25126454      PMCID: PMC4131994          DOI: 10.5826/dpc.0403a04

Source DB:  PubMed          Journal:  Dermatol Pract Concept        ISSN: 2160-9381


× No keyword cloud information.
Actinic granuloma is a rare, idiopathic disorder of middle-aged adults that always appears in sun-exposed skin [1,2]. It is a form of granulomatous dermatosis characterized by annular plaques with central atrophy and raised erythematous margins that are similar to those observed in granuloma annulare (GA) [3]. A 42-year-old man presented with a three-month history of an asymptomatic erythematous annular and serpiginous lesion on his forehead. There was no history of preceding trauma to the area. He was not on any medications. Examination revealed an erythematous to brown annular to serpiginous plaque with central atrophy (Figure 1). Systemic examination revealed no abnormalities. Results of full blood count and multiple biochemical analyses were unremarkable.
Figure 1.

Erythematous to brown annular-like plaque with signs of atrophy at the center. [Copyright: ©2014 Yaghoob et al.]

Skin biopsy showed normal epidermis with significant solar elastosis and granulomatous reaction in dermis, composed of numerous multinucleated giant cells. There was no area of necrobiosis. Verhoeff von Gieson stained sections revealed loss of elastic fiber in the center but the presence of fragments of elastin within the giant cells (Figure 2). Alcian blue staining was negative of mucin (Figure 3).
Figure 2.

Verhoeff von Gieson stained sections revealed loss of elastic fiber in the center but presence of fragments of elastin within the giant cells. [Copyright: ©2014 Yaghoob et al.]

Figure 3.

Alcian blue staining was negative for mucinosis. [Copyright: ©2014 Yaghoob et al.]

O’Brien’s actinic granuloma is a chronic disease that affects middle-aged individuals of either sex who have a history of intense sun exposure [3]. It begins as small skin-colored or pink papules that quickly evolve into annular plaques. The border of the lesion extends slowly at the periphery while the center returns to a slightly atrophic appearance [1]. The pathogenesis of the condition is unknown; however, solar elastosis of sun damage is believed to be a triggering factor [1,3]. It is also reported in association with prolonged doxycycline [4]. O’Brien, who initially described actinic granuloma in 1975 postulated that actinic damaged elastic fibers are the antigenic stimuli that trigger the inflammatory process leading to reparation of sun damaged connective tissue [5,6]. Annular elastolytic giant cell granuloma (AEGCG) was proposed by Henke et al. and used to describe a clinically and histologically similar cutaneous eruption not limited to sun exposure and without solar elastosis [6]. These two conditions may represent a single diagnostic entity and have been grouped under the title “granular elastolytic giant cell granuloma” and proposed as a diagnosis for all annular lesions exhibiting a zonal histologic pattern that includes a granulomatous response with giant cells at the annular rim and centrally a loss of elastic fibers or solar elastotic material [7]. Clinical differentials include facial lesions of granuloma annulare, necrobiosis lipoidica and annular sarcoid. These can be distinguished readily on histopathological features [8,9]. The characteristic histopathologic feature of actinic granuloma is multinucleated foreign body giant cells, which phagocytize the degenerated elastic fibers, a process known as elastophagocytosis. There is an absence of necrobiosis, such as facial necrobiosis lipoidica, or mucinosis, such as GA or sarcoid-like granuloma in the dermis at the solar elastosis level [1,3]. Several forms of treatment with varying results have been reported, such as with chloroquine, cyclosporine, intralesional steroids, cryotherapy, methotrexate, isotretinoin, acitretin, pentoxiphylline, and retinoid psoralen + UVA (RePUVA) [3,10]. Spontaneous remission has been reported in some cases [3]. We report the present case of actinic granuloma because this condition is extremely rare, and patients often do not complain of it. Consequently, any instances may not be brought to medical attention. Our patient was advised to strictly sun protect. He was lost to follow up.
  8 in total

1.  O'Brien's actinic granuloma: an unusually extensive presentation.

Authors:  Rosana Lazzarini; Anita Rotter; Debora Cadore de Farias; Helena Muller
Journal:  An Bras Dermatol       Date:  2011 Mar-Apr       Impact factor: 1.896

2.  Necrobiosis lipoidica with elastophagocytosis on an unusual location.

Authors:  Shang-Ian Tee; Qi Ping Chen; Yen Loo Lim
Journal:  Am J Dermatopathol       Date:  2014-09       Impact factor: 1.533

3.  Actinic granuloma successfully treated with acitretin.

Authors:  C Stefanaki; A Panagiotopoulos; P Kostakis; K Stefanaki; A Petridis
Journal:  Int J Dermatol       Date:  2005-02       Impact factor: 2.736

4.  O'Brien's actinic granuloma in association with prolonged doxycycline phototoxicity.

Authors:  Davin S Lim; Joe Triscott
Journal:  Australas J Dermatol       Date:  2003-02       Impact factor: 2.875

5.  [Annular elastolytic giant-cell granuloma].

Authors:  Y Le Corre; M Steff; B Prophette; P Celerier; H Maillard
Journal:  Ann Dermatol Venereol       Date:  2009-05-28       Impact factor: 0.777

6.  Actinic granuloma. An annular connective tissue disorder affecting sun- and heat-damaged (elastotic) skin.

Authors:  J P O'Brien
Journal:  Arch Dermatol       Date:  1975-04

7.  Granuloma multiforme: a report from India.

Authors:  Rashmi Kumari; Devinder Mohan Thappa; Abhijit Chougule; Balaji Adityan
Journal:  Indian J Dermatol Venereol Leprol       Date:  2009 May-Jun       Impact factor: 2.545

8.  Elastolytic giant cell granuloma: clinic-pathologic review of twenty cases.

Authors:  Enrique Gutierrez-Gonzalez; Silvia Gomez-Bernal; Adriana Alvarez-Perez; Dolores Sanchez-Aguilar; Jaime Toribio
Journal:  Dermatol Online J       Date:  2013-10-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.